Available to SourceHuman Prescription DrugDiabetes & Endocrine

Yorvipath (Palopegteriparatide)

168 ug/.56mL · Injection Solution

By Ascendis Pharma, Endocrinology, Inc.

Palopegteriparatide · Injectable Solution · 168 ug/.56mL · Subcutaneous

NDC: 73362-100
Route: Subcutaneous
Therapeutic class: Parathyroid Hormone Analog , Parathyroid Hormone [CS]
Marketing category: NDA

Package sizes

2 BOX in 1 CARTON (73362-100-01) / 1 SYRINGE in 1 BOX (73362-100-02) / 1 CARTRIDGE in 1 SYRINGE (73362-100-03) / .56 mL in 1 CARTRIDGENDC 73362-100-01Available to Order

Request This Medication

*Expect a reply within 2 business hours with availability and pricing.

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.

Request a quote

Request this medication.

Pick the package size you need and we’ll respond with availability, lot details, dating, and pricing within 2 business hours. Mark it as Rush or Emergency if you need it faster.

DSCSA-compliant pedigree on every order
Cold-chain capable where applicable
Same-day fulfillment available for urgent needs

Related in Diabetes & Endocrine

See all →

Yorvipath (Palopegteriparatide)

Package sizes

Additional information

Request this medication.

Related in Diabetes & Endocrine

Omeosport

Guna-Geriatrics

Procort (1.85% Hydrocortisone Acetate - 1.15% Pramoxine Hci Cream)

1% Hydrocortisone